Please provide your email address to receive an email when new articles are posted on . For the TARGET trial, presented at the American College of Cardiology Scientific Session and simultaneously ...

NEW ORLEANS, LA — Entry to a large randomized clinical-outcomes trial was stopped early after its data and safety monitoring board (DSMB) saw a significant jump in early mortality in patients ...

April 11 (UPI) --A newly developed, non-invasive imaging test can help identify which patients with coronary artery blockage or narrowing need angioplasty or a bypass procedure, a U.S. study published ...

FAMOUS-NSTEMI is the latest clinical trial to assess benefits of St. Jude Medical PressureWireTM technology in expanded patient populations ST. PAUL, Minn. & BARCELONA, Spain -- St. Jude Medical, Inc.

Physiological assessment with fractional flow reserve (FFR) is no better than angiography when it comes to guiding complete revascularization in STEMI patients with multivessel disease who’ve ...

LONDON--(BUSINESS WIRE)--The fractional flow reserve devices market is expected to grow by USD 446.64 million, progressing at a CAGR of over 12% during the forecast period. Click & Get Free Sample ...

LONDON--(BUSINESS WIRE)--The fractional flow reserve devices market is poised to grow by USD 446.64 million during 2020-2024, progressing at a CAGR of about 12% during the forecast period. Request ...

Observational data suggested no benefit to preoperative flow assessment for patients with first-time isolated CABG. Flow assessment would ostensibly have been used to guide decisions on whether to ...